Lydie Poitout
Centre national de la recherche scientifique
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Lydie Poitout.
Bioorganic & Medicinal Chemistry | 1997
Yves Le Merrer; Lydie Poitout; Jean-Claude Depezay; Isabelle Dosbaa; Sabine Geoffroy; Marie-José Foglietti
A series of enantiomerically pure azasugars (2,5-dideoxy-2, 5-imino-D-mannitol, 1-deoxynojirimycin, 1-deoxymannojirimycin, and related compounds) was synthesized from D-mannitol via aminoheterocyclization of C2-symmetric bis-epoxides and subsequently followed by ring isomerization in few cases. These compounds have been evaluated as inhibitors of several glycosidases (alpha- and beta-D-glucosidases, alpha-D-mannosidase and alpha-L-fucosidase). Inhibition studies indicate notably that the polyhydroxylated azepanes are inhibitors of glycosidases, with Ki in the micromolar range.
Tetrahedron Letters | 1994
Lydie Poitout; Yves Le Merrer; Jean-Claude Depezay
Abstract D -mannitol and L -iditol bis-epoxides, easily obtained from D -mannitol, are convenient substrates for the synthesis of polyhydroxylated piperidines and azepanes, via a nucleophilic opening of one epoxy function followed by a spontaneous intramolecular ring closure. Using this strategy 1-deoxynojirimycin and analogues were prepared.
Tetrahedron Letters | 1995
Lydie Poitout; Yves Le Merrer; Jean-Claude Depezay
Abstract 6-Amino-2,5-anhydro-6-deoxy- D -gluconic and L -gulonic acid derivatives, conformationally restricted sugar-like amino-carboxylic acids which mimic dipeptides, have been synthesized by a silica gel assisted azidolysis of enantiomerically pure bis-epoxides.
Bioorganic & Medicinal Chemistry Letters | 1996
Dominique Damour; Michel Barreau; Jean-Charles Blanchard; Marie-Claude Burgevin; Adam Doble; Frédéric Herman; Guy Pantel; Evelyne James-Surcouf; Marc Vuilhorgne; Serge Mignani; Lydie Poitout; Yves Le Merrer; Jean-Claude Depezay
Abstract Based on molecular modelling studies of Sandostatin®, sugar-based derivatives I-VI were prepared as potential non-peptide mimics of somatostatin/Sandostatin®. These compounds displaced 3-[ 125 I]-Tyr 11 -SRIF-14 from the somatostatin receptor on membranes of rat cerebral cortex with IC 50 values between 10 and 15 μM.
Tetrahedron Letters | 1996
Lydie Poitout; Yves Le Merrer; Jean-Claude Depezay
Abstract Isomerization of enantiopure C2-symmetric 3,5-dihydroxyazepane derivatives has been studied. The neighboring nitrogen participation occurs during mesylation to give a chloromethylpiperidine, whereas from the l -ido- azepane a chiral bridged morpholine structure (1R-(6endo, 7exo)-8-oxa-3-azabicyclo[3.2.1]octane-6,7-diol) is obtained under Mitsunobu conditions.
Bioorganic & Medicinal Chemistry Letters | 2001
Marie-Odile Contour-Galcera; Lydie Poitout; Christophe Moinet; Barry Morgan; Thomas D. Gordon; Pierre Roubert; Christophe Thurieau
A new preparation of trisubstituted imidazopyrazines and dihydroimidazopyrazines via parallel synthesis using aminoacids and bromoketones resulted in the discovery of non-peptidic sst5 selective agonists.
Tetrahedron Letters | 1996
Lydie Poitout; Yves Le Merrer; Jean-Claude Depezay
Abstract N- Benzyl -3,4- di -O- benzyl-1,5-dideoxy-1,5-imino- d -glucitol and l -gulitol undergo easy isomerization, mainly either by ring contraction, or either by SN 2 inversion at C2. This isomerization performed by bis-hydroxyl activation allows to access to 2,5-dideoxy-2,5-imino- l -iditol, 5-epi-DNJ, DMDP, and DMJ.
Bioorganic & Medicinal Chemistry Letters | 2001
Christophe Moinet; Marie-Odile Contour-Galcera; Lydie Poitout; Barry Morgan; Thomas D. Gordon; Pierre Roubert; Christophe Thurieau
A series of imidazole derivatives has been prepared using high throughput parallel synthesis. Several compounds showed high affinity (Ki in 10(-6)-10(-8) M range) and selectivity at recombinant human somatostatin receptor subtype 3 (hsst3).
Methods in molecular medicine | 1999
Yves Le Merrer; Lydie Poitout; Jean-Claude Depezay
Poor oral bioavailability, low metabolic stability towards proteolysis and rapid excretion via both liver and kidneys displayed by innumerable peptides of potential therapeutic value has generated an intensive search for peptidomimics (1-2). A possible approach of such nonpeptidal peptidomimics is to replace the peptide by a scaffold that distributes in the space the peptidal side chains of amino acids essential for biological activity and mimics the bioactive conformation of the peptide.
Journal of Medicinal Chemistry | 2001
Lydie Poitout; Pierre Roubert; Marie-Odile Contour-Galcera; Christophe Moinet; Jacques Lannoy; Jacques Pommier; Pascale Plas; Dennis Bigg; Christophe Thurieau